Gilman Hill Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.32M | Buy |
|
|||||
|
2025
Q2 | $4.56M | Buy |
|
|||||
|
2025
Q1 | $2.71M | Buy |
|
|||||
|
2024
Q4 | $2.17M | Sell |
|
|||||
|
2024
Q3 | $2.76M | Buy |
|
|||||
|
2024
Q2 | $2.37M | Buy |
|
|||||
|
2024
Q1 | $2.46M | Buy |
|
|||||
|
2023
Q4 | $2.02M | Sell |
|
|||||
|
2023
Q3 | $2.19M | Sell |
|
|||||
|
2023
Q2 | $2.2M | Buy |
|
|||||
|
2023
Q1 | $1.98M | Buy |
|
|||||
|
2022
Q4 | $1.82M | Sell |
|
|||||
|
2022
Q3 | $1.63M | Sell |
|
|||||
|
2022
Q2 | $3.08M | Buy |
|
|||||
|
2022
Q1 | $3.04M | Buy |
|
|||||
|
2021
Q4 | $2.81M | Sell |
|
|||||
|
2021
Q3 | $2.48M | Buy |
|
|||||
|
2021
Q2 | $2.39M | Buy |
|
|||||
|
2021
Q1 | $2.14M | Buy |
|
|||||
|
2020
Q4 | $2.08M | Buy |
|
|||||
|
2020
Q3 | $1.31M | Sell |
|
|||||
|
2020
Q2 | $1.46M | Sell |
|
|||||
|
2020
Q1 | $1.38M | Buy |
|
|||||
|
2019
Q4 | $1.68M | Buy |
|
|||||
|
2019
Q3 | $1.49M | Sell |
|
|||||
|
2019
Q2 | $1.4M | Buy |
|
|||||
|
2019
Q1 | $1.41M | Buy |
|
|||||
|
2018
Q4 | $1.24M | Sell |
|
|||||
|
2018
Q3 | $1.37M | Buy |
|
|||||
|
2018
Q2 | $1.3M | Buy |
|
|||||
|
2018
Q1 | $1.24M | Buy |
|
|||||
|
2017
Q4 | $1M | Sell |
|
|||||
|
2017
Q3 | $1.15M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Buy |
|
|||||
|
2017
Q1 | $999K | Buy |
|
|||||
|
2016
Q4 | $636K | Sell |
|
|||||
|
2016
Q3 | $896K | Buy |
|
|||||
|
2016
Q2 | $814K | Buy |
|
|||||
|
2016
Q1 | $657K | Buy |
|
|||||
|
2015
Q4 | $518K | Sell |
|
|||||
|
2015
Q3 | $559K | Buy |
|
|||||
|
2015
Q2 | $605K | Sell |
|
|||||
|
2015
Q1 | $770K | Buy |
|
|||||
|
2014
Q4 | $671K | Sell |
|
|||||
|
2014
Q3 | $735K | Buy |
|
|||||
|
2014
Q2 | $631K | Buy |
|
|||||
|
2014
Q1 | $380K | Buy |
|
|||||
|
2013
Q4 | $227K | Buy |
|